|Videos|March 3, 2023
Circulating Tumor DNA and its Use in Colorectal Cancer Treatment Decision-Making
Aparna Parikh, MD, MS, defines circulating tumor DNA (ctDNA) and the use of ctDNA assays in colorectal cancer.
Advertisement
Episodes in this series
Advertisement
Related to this article
More than half of patients with microsatellite-stable metastatic colorectal cancer without active liver metastases survived at least 18 months with botensilimab plus balstilimab.
Advertisement
Advertisement
Trending on CancerNetwork
1
Azacitidine Plus Ruxolitinib Shows Durable Responses in Myelofibrosis
2
Defining the Optimal Window for Cytoreductive SABR in Metastatic Kidney Cancer
3
Rusfertide Improves Hematocrit Control vs Placebo in Polycythemia Vera
4
Building Systems to Catch Liver and Other Cancers in Patients With MASLD
5